Product Review – Intravenous landiolol hydrochloride for short-term rate control of tachyarrhythmias

This review discusses the use of intravenous landiolol for short-term ventricular rate control in patients with tachyarrhythmias in acute settings, including postoperative atrial fibrillation, heart failure, and sepsis-induced tachyarrhythmias.

Guiding commentary has been provided by Professor Andrew Sindone, the Director of the Heart Failure Unit and Department of Cardiac Rehabilitation at Concord Hospital, and Consultant Cardiologist at Ryde Hospital in Sydney. He holds academic appointments at the University of Sydney and Western Sydney University.

Please login below to download this issue (PDF)

Subscribe